Key Laboratory of Biological Medicines in Universities of Shandong Province, Weifang Key Laboratory of Antibody Medicines, School of Bioscience and Technology, Weifang Medical University, Jinan, 261053, Shandong, China.
Institute for Translational Medicine, Qingdao University, Qingdao, 266021, China.
BMC Genomics. 2021 Nov 24;22(1):850. doi: 10.1186/s12864-021-08148-2.
The detection and identification of single nucleotide polymorphism (SNP) is essential for determining patient disease susceptibility and the delivery of medicines targeted to the individual. At present, SNP genotyping technology includes Sanger sequencing, TaqMan-probe quantitative polymerase chain reaction (qPCR), amplification-refractory mutation system (ARMS)-PCR, and Kompetitive Allele-Specific PCR (KASP). However, these technologies have some disadvantages: the high cost of development and detection, long and time consuming protocols, and high false positive rates. Focusing on these limitations, we proposed a new SNP detection method named universal probe-based intermediate primer-triggered qPCR (UPIP-qPCR). In this method, only two types of fluorescence-labeled probes were used for SNP genotyping, thus greatly reducing the cost of development and detection for SNP genotyping.
In the amplification process of UPIP-qPCR, unlabeled intermediate primers with template-specific recognition functions could trigger probe hydrolysis and specific signal release. UPIP-qPCR can be used successfully and widely for SNP genotyping. The sensitivity of UPIP-qPCR in SNP genotyping was 0.01 ng, the call rate was more than 99.1%, and the accuracy was more than 99.9%. High-throughput DNA microarrays based on intermediate primers can be used for SNP genotyping.
This novel approach is both cost effective and highly accurate; it is a reliable SNP genotyping method that would serve the needs of the clinician in the provision of targeted medicine.
单核苷酸多态性(SNP)的检测和鉴定对于确定患者的疾病易感性和针对个体的靶向药物的递送至关重要。目前,SNP 基因分型技术包括 Sanger 测序、TaqMan 探针定量聚合酶链反应(qPCR)、扩增不可避免突变系统(ARMS)-PCR 和 Kompetitive Allele-Specific PCR(KASP)。然而,这些技术存在一些缺点:开发和检测成本高、耗时且冗长,以及高假阳性率。针对这些局限性,我们提出了一种新的 SNP 检测方法,命名为通用探针中间引物触发 qPCR(UPIP-qPCR)。在这种方法中,仅使用两种类型的荧光标记探针进行 SNP 基因分型,从而大大降低了 SNP 基因分型的开发和检测成本。
在 UPIP-qPCR 的扩增过程中,具有模板特异性识别功能的非标记中间引物可以触发探针水解和特异性信号释放。UPIP-qPCR 可成功且广泛地用于 SNP 基因分型。UPIP-qPCR 在 SNP 基因分型中的灵敏度为 0.01ng,检出率超过 99.1%,准确性超过 99.9%。基于中间引物的高通量 DNA 微阵列可用于 SNP 基因分型。
这种新方法既经济又准确;它是一种可靠的 SNP 基因分型方法,可满足临床医生提供靶向药物的需求。